$1.12
▼ -1.6% Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
Overview
52-week range
$1.01
$24
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-21.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.25 | — | — | +43.2% | -37.1% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.39 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.44 | — | — | — | -5.0% | earnings |
| Sun Jun 30, 2024 | Jun 2024 | $-43.48 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.00 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-7.73 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $8M | — | $9M | $9M | $9M | — | $8M |
| Cost of revenue | $7M | $6M | — | $6M | $6M | $6M | — | $6M |
| Gross profit | $2M | $2M | — | $3M | $3M | $3M | — | $3M |
| Operating income | $-2M | $-1M | — | $-1M | $-2M | $-1M | — | $-1M |
| Net income | $-2M | $-1M | — | $-883,820 | $-2M | $-1M | — | $-1M |
| EPS (diluted) | — | — | — | — | $-0.82 | $-0.44 | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $12M | $13M | $13M | $14M | $13M | $12M | $11M | $10M |
| Total current assets | $31M | $25M | $27M | $28M | $28M | $24M | $26M | $26M |
| Total assets | $34M | $28M | $30M | $31M | $32M | $29M | $31M | $30M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $6M | $7M | $7M | $6M | $6M | $7M | $5M |
| Total equity | $28M | $22M | $23M | $24M | $26M | $23M | $24M | $25M |
Implied volatility — last 90 days
No IV snapshots yet for SBFM.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.